Dexorder
Dexorder is a blockchain company that offers a DeFi trading system that connects traders directly with global liquidity.
Dexorder is a blockchain company that offers a DeFi trading system that connects traders directly with global liquidity.
Dexorder has raised $50k across 1 round. Its most recent round was a Pre-Seed of $50k in Nov 2025. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Dexorder is featured in
Similar companies
Blockstreet is a multichain platform driving USD1 stablecoin adoption, smart contract deployment, and cross-chain DeFi growth tools.
Mavryk Network is a Defi ecosystem that offers instant lending, liquidity mining, yield farming, and other DeFi opportunities.
Red Cat is creating a complete drone supply chain that includes secure blockchain-based storage, analytics, and software as a service solutions for use in the drone sector.
Hospitri is a platform for Vacation Rental Management as a Service (VRMaaS) that aims to assist property managers and owners in automating, optimizing, and expanding their businesses.
Punybz facilitates corporate digital transformation with solutions that blend creativity, technology, and agility.
SOLX is a manufacturing company that develops and retails solar panels.
We are expanding the capabilities of marine aquaculture to deep-water fish, at scale, sustainably, and with premium quality
Island (ASX: ILA) is a drug repurposing company, focused on the rapid development of antiviral therapeutics for infectious diseases. We have a lead asset – ISLA-101 - that was initially developed by our wholly-owned subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquitoes (or vector) borne diseases. Dengue fever is the very definition of an unmet medical need. While 390 million humans are infected each year, it is thought that around 30-50% of people with the disease do not present with symptoms, enabling the virus to spread within communities. Warming global climates are accelerating the presence of mosquito-borne viruses that can cause death to the US, Europe and Australia There is no specific pharmaceutical treatment and the one vaccine which exists is available to a highly restricted audience. Island has repurposed ISLA-101, an antiviral oral drug to treat mosquito-borne viruses (eg dengue fever / Zika) and intends to complete Phase II studies with a significantly de-risked clinical program.
Raincoat creates efficient embedded insurance products for climate events and the automated systems that support them. They collaborate with insurance companies, government entities, and financial organizations to expand into new markets and promote widespread climate resilience.
Raincoat specializes in creating embedded climate insurance products and the advanced infrastructure required to support them. They collaborate with insurance companies, governments, and financial organizations to expand into untapped markets and promote widespread climate resilience.
Gulp Data is a fast, Dilution-Free Funding by Leveraging your Data.
Intuition provides decentralized infrastructure, developer tools, and applications enabling the creation of an open, flexible knowledge graph enhancing the quality and availability of social knowledge.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.